Search - tctmd.com

Displaying 81 - 100 of 176

Sort: Relevancy | Date

News Conference News EuroPCR 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

L.A. McKeown

May 23, 2019

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

Presentation ISET 2019

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

Presenter: Gervasio A. Lamas

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Conference News VIVA 2018

LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation

L.A. McKeown

November 07, 2018

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

Presentation TCT Abstracts Posters 2018

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Presenter: Aleksandra Kolarczyk-Haczyk1

September 25, 2018

Presentation TCT 2018

Complex Multilevel Critical Limb Ischemia

Presenter: Sahil A. Parikh, Christopher J. White, Vikas Aggarwal, J. Michael Bacharach, Brian G. DeRubertis, Virendra I Patel, Mahmood K. Razavi, Rahul Sakhuja, Ramon L Varcoe, Craig M. Walker

September 24, 2018

Presentation TCT 2018

Intravascular Lithotripsy for Treatment of Calcified Tibial Vessels

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Ramon L Varcoe

September 22, 2018

Presentation TCT 2018

Drug-Eluting Stents For Tibial Disease: Data and Case Examples

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Robert A. Lookstein

September 22, 2018

Presentation TCT 2018

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Carlos I. Mena-Hurtado

September 22, 2018

Presentation TCT 2018

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Bryan T. Fisher

September 22, 2018

Advertisement

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Complex Multilevel Critical Limb Ischemia

Intravascular Lithotripsy for Treatment of Calcified Tibial Vessels

Drug-Eluting Stents For Tibial Disease: Data and Case Examples

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content